Reduced levels of interleukin 33 and increased levels of soluble ST2 in subjects with amyotrophic lateral sclerosis

被引:32
|
作者
Lin, C. Y. [1 ]
Pfluger, C. M. [1 ]
Henderson, R. D. [1 ]
McCombe, P. A. [1 ]
机构
[1] Univ Queensland, Clin Res Ctr, Brisbane, Qld 4072, Australia
基金
英国医学研究理事会;
关键词
Amyotrophic lateral sclerosis; Apoptosis; Cytokines; Interleukin; 33; Soluble ST2; Neuroinflammation; CENTRAL-NERVOUS-SYSTEM; IL-33; RECEPTOR; DISEASE; CELLS; INITIATION; SECRETION; INSIGHTS; BIOLOGY; IMMUNE;
D O I
10.1016/j.jneuroim.2012.05.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin 33 (IL-33) is a cytokine that functions as an alarmin and is released from damaged tissue. The receptor for IL-33 is ST2, which exists as membrane bound and soluble forms. Levels of IL-33 and soluble ST2 (sST2) are elevated in some inflammatory diseases. Amyotrophic lateral sclerosis (ALS) is a disease that is due to loss of motor neurones, with some neuro-inflammation at the site of pathology. This study was performed to measure levels of IL-33 and sST2 in ALS. Serum was obtained from subjects with ALS (n=42) and healthy controls (n=38). Levels of IL-33 and s ST2 were measured with ELISA. The level of II-33 was significantly lower in ALS subjects than healthy controls, and the levels of sST2 were significantly higher. The lower levels of IL-33 could be due to degradation of IL-33 by caspases released from apoptotic cells. However the levels of IL-33 could also be lower due to effects of sST2 which acts as a receptor for IL-33. The levels of sST2 could reflect inflammation in ALS. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:93 / 95
页数:3
相关论文
共 50 条
  • [41] Blood levels of trace metals and amyotrophic lateral sclerosis
    Peters, Tracy L.
    Beard, John D.
    Umbach, David M.
    Allen, Kelli
    Keller, Jean
    Mariosa, Daniela
    Sandler, Dale P.
    Schmidt, Silke
    Fang, Fang
    Ye, Weimin
    Kamel, Freya
    NEUROTOXICOLOGY, 2016, 54 : 119 - 126
  • [42] An exploratory study of serum creatinine levels in patients with amyotrophic lateral sclerosis
    Chen, Xueping
    Guo, Xiaoyan
    Huang, Rui
    Zheng, Zhenzhen
    Chen, Yongping
    Shang, Hui-fang
    NEUROLOGICAL SCIENCES, 2014, 35 (10) : 1591 - 1597
  • [43] Serum anti-Fas antibody levels in amyotrophic lateral sclerosis
    Sengun, IS
    Appel, SH
    JOURNAL OF NEUROIMMUNOLOGY, 2003, 142 (1-2) : 137 - 140
  • [44] Increased Serum Levels of Soluble ST2 in Birch Pollen Atopics and Individuals Working in Laboratory Animal Facilities
    Sahlander, Karin
    Larsson, Kjell
    Palmberg, Lena
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2010, 52 (02) : 214 - 218
  • [45] IL-33 and soluble ST2 levels as novel predictors for remission and progression of carotid plaque in early rheumatoid arthritis: A prospective study
    Shen, Jiayun
    Shang, Qing
    Wong, Chun-Kwok
    Li, Edmund K.
    Wang, Shang
    Li, Rui-Jie
    Lee, Ka-Lai
    Leung, Ying-Ying
    Ying, King-Yee
    Yim, Cheuk-Wan
    Kun, Emily W.
    Leung, Moon-Ho
    Li, Martin
    Li, Tena K.
    Zhu, Tracy Y.
    Yu, Shui-Lian
    Kuan, Woon-Pang
    Yu, Cheuk-Man
    Tam, Lai-Shan
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 45 (01) : 18 - 27
  • [46] YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
    Andres-Benito, Pol
    Dominguez, Raul
    Colomina, Maria J.
    Llorens, Franc
    Povedano, Monica
    Ferrer, Isidre
    AGING-US, 2018, 10 (09): : 2367 - 2382
  • [47] Soluble ST2 levels in patients with cardiogenic and septic shock are not predictors of mortality
    Parenica, Jiri
    Malaska, Jan
    Jarkovsky, Jiri
    Lipkova, Jolana
    Dastych, Milan
    Helanova, Katerina
    Litzman, Jiri
    Tomandl, Josef
    Littnerova, Simona
    Sevcikova, Jana
    Gal, Roman
    Sevcik, Pavel
    Spinar, Jindrich
    Goldbergova, Monika Pavkova
    EXPERIMENTAL & CLINICAL CARDIOLOGY, 2012, 17 (04) : 205 - 209
  • [48] Increased interleukin-6 of skin and serum in amyotrophic lateral sclerosis
    Ono, S
    Hu, SG
    Shimizu, N
    Imai, T
    Nakagawa, H
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 187 (1-2) : 27 - 34
  • [49] Serum levels of IL-33 and its receptor ST2 are elevated in patients with ankylosing spondylitis
    Li, G-X
    Wang, S.
    Duan, Z-H
    Zeng, Z.
    Pan, F-M
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (03) : 226 - 231
  • [50] Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still's Disease
    Han, Jae Ho
    Suh, Chang-Hee
    Jung, Ju-Yang
    Ahn, Hyun
    Kwon, Ji Eun
    Yim, Hyunee
    Kim, Hyoun-Ah
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 740 - 747